BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20928983)

  • 1. Early pregnancy failure: factors affecting successful medical treatment.
    Odeh M; Tendler R; Kais M; Maximovsky O; Ophir E; Bornstein J
    Isr Med Assoc J; 2010 Jun; 12(6):325-8. PubMed ID: 20928983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of βhCG monitoring in the follow-up of medical management of miscarriage.
    Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):358-365. PubMed ID: 28345139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol for medical evacuation of early pregnancy failure.
    Creinin MD; Moyer R; Guido R
    Obstet Gynecol; 1997 May; 89(5 Pt 1):768-72. PubMed ID: 9166318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
    Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravaginal misoprostol 600 microg and 800 microg for the treatment of early pregnancy failure.
    Kovavisarach E; Jamnansiri C
    Int J Gynaecol Obstet; 2005 Sep; 90(3):208-12. PubMed ID: 15967450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
    Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
    Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
    Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
    J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of first trimester missed miscarriage: the efficacy and complication rate.
    Serdinšek T; Reljič M; Kovač V
    J Obstet Gynaecol; 2019 Jul; 39(5):647-651. PubMed ID: 30917727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol for early pregnancy failure.
    Stockheim D; Carp H
    Isr Med Assoc J; 2010 Jun; 12(6):375-6. PubMed ID: 20928994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Misoprostol in substitution at uterine curettage in early pregnancy failure].
    Arcanjo FC; Ribeiro AS; Teles TG; Macena RH; Carvalho FH
    Rev Bras Ginecol Obstet; 2011 Jun; 33(6):276-80. PubMed ID: 21877016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal ultrasound measurement of cervical length and efficacy of misoprostol in first-trimester pregnancy failure.
    Agostini A; Capelle M; Ronda I; Bretelle F; Cravello L; Blanc B
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):671-3. PubMed ID: 17427895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed abortion and application of misoprostol.
    Zeqiri F; Paçarada M; Kongjeli N; Zeqiri V; Kongjeli G
    Med Arh; 2010; 64(3):151-3. PubMed ID: 20645507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.
    Reeves MF; Lohr PA; Harwood BJ; Creinin MD
    Obstet Gynecol; 2008 Jan; 111(1):106-12. PubMed ID: 18165398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic appearance of the uterine cavity following administration of mifepristone and misoprostol for termination of pregnancy.
    Markovitch O; Tepper R; Klein Z; Fishman A; Aviram R
    J Clin Ultrasound; 2006; 34(6):278-82. PubMed ID: 16788959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
    Reeves MF; Kudva A; Creinin MD
    Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Machtinger R; Stockheim D; Seidman DS; Lerner-Geva L; Dor J; Schiff E; Shulman A
    Fertil Steril; 2009 May; 91(5):1881-5. PubMed ID: 18455163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Termination of Delayed Miscarriage: Four-Year Experience with an Outpatient Protocol.
    Lyra J; Cavaco-Gomes J; Moucho M; Montenegro N
    Rev Bras Ginecol Obstet; 2017 Oct; 39(10):529-533. PubMed ID: 28850998
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with misoprostol in the management of missed abortion in the second trimester.
    Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
    J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.